Literature DB >> 31059823

Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review.

Maria N Wilson1, Jill A Hayden1, Emily Rhodes1, Alysia Robinson1, Mark Asbridge2.   

Abstract

Prescription monitoring programs (PMPs) house and monitor data about the prescribing practices of health care providers, as well as medications received by patients. PMPs aim to promote the appropriate use of prescription opioids by providing this information to prescribers and dispensers. Our objective in this systematic review was to comprehensively identify and assess the available evidence about the impact of PMPs on opioid prescribing and dispensing, multiple provider use for obtaining opioids, inappropriate opioid prescribing, and the extent of nonmedical prescription opioid use. We used a comprehensive search strategy and included study designs that could determine changes in outcomes with the implementation of a PMP. We included 24 studies; 75% of studies were conducted in the United States, and studies encompassed data years from 1993 to 2014. Overall, we did not find evidence to support an association between PMPs and decreased opioid prescribing and dispensing. We found limited, but inconsistent, evidence that PMPs were associated with reduced schedule II opioid prescribing and dispensing, as well as multiple provider use. Covariate adjustment was often inadequate in analyses, as was the timing of outcome and PMP measurement. Future studies should broaden their geographic scope to other countries and use more recent data with standard measurement. PERSPECTIVE: This systematic review aimed to determine the effectiveness of PMPs in changing prescribing practices and prescription opioid use. The findings from this review will inform policymakers and PMP administrators about the current state of the evidence on program effectiveness.
Copyright © 2019 the American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Prescription monitoring programs; drug diversion; evaluation; opioids; prescription drugs

Mesh:

Substances:

Year:  2019        PMID: 31059823     DOI: 10.1016/j.jpain.2019.04.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  14 in total

Review 1.  Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.

Authors:  Esad Ulker; Egidio Del Fabbro
Journal:  Oncologist       Date:  2019-12-24

2.  Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States.

Authors:  Victor Puac-Polanco; Stanford Chihuri; David S Fink; Magdalena Cerdá; Katherine M Keyes; Guohua Li
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

3.  Prescription Drug Monitoring Programs - Friend or Folly in Addressing the Opioid-Overdose Crisis?

Authors:  Rebecca L Haffajee
Journal:  N Engl J Med       Date:  2019-08-22       Impact factor: 91.245

4.  "1,000 conversations I'd rather have than that one:" A qualitative study of prescriber experiences with opioids and the impact of a prescription drug monitoring program.

Authors:  Jillian Zavodnick; Alexis Wickersham; Alison Petok; Brooke Worster; Amy Leader
Journal:  J Addict Dis       Date:  2022-02-08

Review 5.  Opioids in Hemodialysis Patients.

Authors:  Sahir Kalim; Karen S Lyons; Sagar U Nigwekar
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 5.299

Review 6.  A systematic review of assessment approaches to predict opioid misuse in people with cancer.

Authors:  Robyn Keall; Paul Keall; Carly Kiani; Tim Luckett; Richard McNeill; Melanie Lovell
Journal:  Support Care Cancer       Date:  2022-02-15       Impact factor: 3.359

7.  Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).

Authors:  Chris Delcher; Nathan Pauly; Patience Moyo
Journal:  Curr Opin Psychiatry       Date:  2020-07       Impact factor: 4.787

8.  A Goal-directed Quality Improvement Initiative to Reduce Opioid Prescriptions After Orthopaedic Procedures.

Authors:  Kevin J Choo; Trevor R Grace; Krishn Khanna; Jeffrey Barry; Erik N Hansen
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2019-09-17

9.  High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018.

Authors:  Sarah J Ball; Kit Simpson; Jingwen Zhang; Justin Marsden; Khosrow Heidari; William P Moran; Patrick D Mauldin; Jenna L McCauley
Journal:  J Public Health Manag Pract       Date:  2021 Jul-Aug 01

10.  Opioid Prescribing After Implementation of Single Click Access to a State Prescription Drug Monitoring Program Database in a Health System's Electronic Health Record.

Authors:  Scott G Weiner; Kimiyoshi Kobayashi; Joshua Reynolds; Kit Chan; Rodd Kelly; Sarah Wakeman; Prabashni Reddy; Leonard D Young
Journal:  Pain Med       Date:  2021-10-08       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.